Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients

Arthur R. Van Gool, Heidi H. van Ojik, Wim H.J. Kruit, Paul Mulder, Durk Fekkes, M. Bannink, Simon Scharpé, G. Stoter, A.M.M. Eggermont, Michael Maes, Robert Verkerk

Article2004

Neoadjuvant Chemotherapy with Docetaxel and Cisplatin in Patients with High-Risk Resectable Bladder Carcinoma: Long Term Results

Aristotelis Bamias, C. Deliveliotis, A. Karayiannis, Ioannis Varkarakis, Iannis M. Zervas, D Pantazopoulos, Dimitra Gika, Meletios A Dimopoulos

Article1993

[Adjuvant interferon alpha in renal carcinoma with a high risk of recurrence. Multicenter pilot study].

Giorgio Pizzocaro, Luigi Piva, M. Faustini, Nicola Nicolai, Roberto Salvioni, Elena Pisani, Aldo Maggioni, A. Mandressi, E Dormia, S. Minervini